NCT05115916

Brief Summary

Behavioral economics principles have increasingly been shown to improve health outcomes in the United States. They offer the ability to implement simple, low-cost and effective interventions to address key health issues without sacrificing the autonomy of patients. Colorectal cancer (CRC) screening is a key area where behavioral economics principles can help improve health outcomes. Despite being the second leading cause of cancer related death, the rate of CRC screening remains well below national targets. Interventions to address these issues, and improve screening rates at our institution have including implementing a Mailed FIT outreach program, and adding an informational letter that utilizes behavioral economic principles. To further improve our screening rates, this project builds upon our previous efforts to include a randomized electronic message primer via patients electronic patient portal, to help alert them of incoming FIT Kit and complete screening. This study will contribute to the growing literature of behavioral economics in medicine, while addressing an important health issue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,880

participants targeted

Target at P75+ for not_applicable colorectal-cancer

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 28, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 10, 2021

Completed
Last Updated

November 10, 2021

Status Verified

November 1, 2021

Enrollment Period

1.1 years

First QC Date

October 28, 2021

Last Update Submit

November 8, 2021

Conditions

Keywords

Colorectal Cancer ScreeningColon CancerNudgeBehavior and Behavior MechanismsBehavioral EconomicsHealth Screening

Outcome Measures

Primary Outcomes (1)

  • Overall Colorectal Cancer Screening Uptake

    Rate of completion of CRC screening by any of the following: FIT, colonoscopy, CT colonography, sigmoidoscopy or FIT-DNA within study period.

    6 months

Secondary Outcomes (3)

  • Time to screening

    6 months

  • Colorectal cancer screening uptake by modality

    6 months

  • Effect of electronic primer message on CRC uptake among participants who opened

    6 months

Study Arms (2)

Standard of Care

NO INTERVENTION

This group will receive standard FIT mailer protocol (includes mailed FIT kit plus standardized messaging via EHR portal)

MyChart Message

EXPERIMENTAL

This group will receive a message via EHR portal informing them about the incoming FIT Kit

Behavioral: MyChart Priming Message

Interventions

In addition to the standard FIT mailer protocol, we will send randomized participants a message via their personal health portal. Patients receive the primer approximately 1-2 weeks prior to arrival of the FIT kit, which informed patients about the incoming FIT Kit and instructed patients to complete and return the kit promptly.

MyChart Message

Eligibility Criteria

Age51 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Managed care patient, 51-75 years old
  • Active primary care provider at UCLA seen within last 3 years

You may not qualify if:

  • Inactive MyChart status or mailing address at time of enrollment
  • Died within follow up period
  • Any high-risk features including first degree family members with CRC, personal history of adenomas, history of inflammatory bowel disease, and any genetic GI cancer syndromes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA Health Department of Medicine, Quality Office

Westwood, Los Angeles, California, 90095, United States

Location

Related Publications (1)

  • Goshgarian G, Sorourdi C, May FP, Vangala S, Meshkat S, Roh L, Han MA, Croymans DM. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e2146863. doi: 10.1001/jamanetworkopen.2021.46863.

MeSH Terms

Conditions

Colorectal NeoplasmsColonic NeoplasmsBehavior

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: 3880 patients 51-75 years old, within the UCLA Health Managed Care group overdue for average risk CRC screening without prior history of documented FIT or colonoscopy will be randomized into 2 groups, in a 1:1 ratio. The 2 groups represent standard of care, and then the MyChart Message group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director, DOM Quality

Study Record Dates

First Submitted

October 28, 2021

First Posted

November 10, 2021

Study Start

August 28, 2019

Primary Completion

September 20, 2020

Study Completion

December 20, 2020

Last Updated

November 10, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

We do not plan to share IPD for this investigation.

Locations